Day: August 14, 2023

Charlie’s Holdings Reports Significantly Reduced Operating Loss to $42,000 for the Second Quarter Ended June 30, 2023

Staff August 14, 2023

Company Plans to Launch SPREE BAR™ - "the Single Largest, Most Important Commercial Product in Charlie's History" - in SeptemberCOSTA...

MicroHealth Wins 2 Stevies in 2023 International Business Awards

Staff August 14, 2023

VIENNA, VA / ACCESSWIRE / August 14, 2023 / MicroHealth LLC, a leading Health Information Technology company, announced today that...

Scientific Industries Reports Financial Results for Second Quarter 2023

Staff August 14, 2023

Benchtop Lab Equipment Revenue Up Led by Torbal Division's 48% Increase - Bioprocessing Revenue Up 41%BOHEMIA, NY / ACCESSWIRE /...

Empatho Holdings Inc. Announces Shares for Debt Settlement

Staff August 14, 2023

Toronto, Ontario--(Newsfile Corp. - August 14, 2023) - Empatho Holdings Inc. (CSE: EMPH) (formerly, Shane Resources Ltd.) ("Empatho" or the...

Assisted Home Health & Hospice Honors Veteran Roger Dawson With Pinning Ceremony

Staff August 14, 2023

We Honor VeteransTHOUSAND OAKS, CA / ACCESSWIRE / August 14, 2023 / Assisted Hospice Care in Phoenix, Arizona, celebrated the...

CBD of Denver (CBDD) Expands on the Plans for Luxora Operations and Initiates Strategic Plans for Both Subsidiaries

Staff August 14, 2023

Denver, Colorado--(Newsfile Corp. - August 14, 2023) - CBD of Denver, Inc. (OTC Pink: CBDD) a leading innovation company, announces...

Zion Healing Inc. Announces $25 Million Private Placement to Fund Innovative Veterans Initiative

Staff August 14, 2023

SAINT GEORGE, UT / ACCESSWIRE / August 14, 2023 / Zion Healing Inc. and its subsidiary, Zion Healing Development Company,...

Sound Physicians & AdventHealth Expand Partnership

Staff August 14, 2023

Hospital medicine staff to care for patients at AdventHealth's newest Flagler County hospitalTACOMA, WA / ACCESSWIRE / August 14, 2023...

Hemostemix Announces Arbitration Award of CAD $315,684 Plus Private Placement

Staff August 14, 2023

Calgary, Alberta--(Newsfile Corp. - August 14, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce...

Virginia Commonwealth University to Offer 23 New Programs with MedCerts Partnership

Staff August 14, 2023

Adult learners gain access to in-demand online certification programs in the healthcare industryRICHMOND, Va.--(BUSINESS WIRE)--#StrideLearn--MedCerts, the innovation leader in online...

GE HealthCare Receives FDA Clearance for Portrait Mobile, A First-Of-Its-Kind, Wireless Monitoring Solution Aiding Early Detection of Patient Deterioration

Staff August 14, 2023

GE HealthCare’s smart phone-sized Portrait Mobile frees the patient from the hospital bed while providing continuous monitoring of vital signs,...

Health Karma(R) Group Announces Partnership with OXIO Health, Inc. to offer access to Centralized Personal Health Record using Artificial Intelligence

Staff August 14, 2023

FORT LAUDERDALE, FL / ACCESSWIRE / August 14, 2023 / MediXall Group Inc. (OTC PINK:MDXL) ("MediXall"), an innovative virtual health...

Curated Mental Health Expands Services to New Location in Williamsburg

Staff August 14, 2023

BROOKLYN, NY / ACCESSWIRE / August 14, 2023 / Curated Mental Health proudly announces its expansion to a new location...

Bio-Conscious Announces Breakthrough in Forecasting Nocturnal Hypoglycemia Events Using Machine Learning (ML) Techniques and CGM data.

Staff August 14, 2023

VANCOUVER, BC / ACCESSWIRE / August 14, 2023 / Bio Conscious Technologies Inc. ("Bio Conscious Technologies" or the "Company"), a...

CNS Pharmaceuticals (NASDAQ: CNSP) Presents Updated Results from On-Going Potentially Pivotal Study of Berubicin in Adult Patients with Recurrent GBM (WHO Grade IV) After Failure of Standard First Line Therapy

Staff August 14, 2023

Data presented at the 2023 SNO/ASCO CNS Cancer ConferenceBerubicin currently being evaluated in an ongoing potentially pivotal study for the...

Day: August 14, 2023

Charlie’s Holdings Reports Significantly Reduced Operating Loss to $42,000 for the Second Quarter Ended June 30, 2023

MicroHealth Wins 2 Stevies in 2023 International Business Awards

Scientific Industries Reports Financial Results for Second Quarter 2023

Empatho Holdings Inc. Announces Shares for Debt Settlement

Assisted Home Health & Hospice Honors Veteran Roger Dawson With Pinning Ceremony

CBD of Denver (CBDD) Expands on the Plans for Luxora Operations and Initiates Strategic Plans for Both Subsidiaries

Zion Healing Inc. Announces $25 Million Private Placement to Fund Innovative Veterans Initiative

Sound Physicians & AdventHealth Expand Partnership

Hemostemix Announces Arbitration Award of CAD $315,684 Plus Private Placement

Virginia Commonwealth University to Offer 23 New Programs with MedCerts Partnership

GE HealthCare Receives FDA Clearance for Portrait Mobile, A First-Of-Its-Kind, Wireless Monitoring Solution Aiding Early Detection of Patient Deterioration

Health Karma(R) Group Announces Partnership with OXIO Health, Inc. to offer access to Centralized Personal Health Record using Artificial Intelligence

Curated Mental Health Expands Services to New Location in Williamsburg

Bio-Conscious Announces Breakthrough in Forecasting Nocturnal Hypoglycemia Events Using Machine Learning (ML) Techniques and CGM data.

CNS Pharmaceuticals (NASDAQ: CNSP) Presents Updated Results from On-Going Potentially Pivotal Study of Berubicin in Adult Patients with Recurrent GBM (WHO Grade IV) After Failure of Standard First Line Therapy

Stemtech Announces China Market Expansion

Biotricity to Host First Quarter Fiscal Year 2024 Financial Results and Business Update Call on August 15th

Halberd-Mississippi State University (MSU) Testing of TBI Nasal Spray Progresses

Jaguar Health Reports Second Quarter 2023 Financial Results

Sonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings Update

TMCI Deadline: Rosen Law Firm Urges Treace Medical Concepts, Inc. (NASDAQ: TMCI) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Introducing Tempus One in the EHR with Integrated Guidelines

Novartis Kisqali® reduces risk of recurrence in younger patients with early breast cancer in NATALEE subgroup analysis

Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults

Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary Endpoint of Median Overall Survival and Doubles 1-Year Survival in First-Line Treatment of Metastatic Pancreatic Cancer

You may have missed